Detection of bla OXA-48 and bla IMP Resistance Genes in Escherichia coli and Klebsiellapneumoniae Isolated from Children with Urinary Tract Infections
DOI:
https://doi.org/10.5281/zenodo.15777196Abstract
Abstract Views: 224
The pathogens Escherichia coli and Klebsiella pneumoniae are often involved in urinary tract infections (UTIs), which are common, especially in children. Due to their association with antibiotic resistance, which makes treatment tactics more difficult, the presence of the bla OXA-48 and bla IMP genes in these bacteria is essential. To detect two resistant genes, bla OXA-48 and bla IMP, in Klebsiella pneumoniae and Escherichia coli and to detect the variant genes by sequencing for each bacterium. In all, one hundred urine samples from children with UTIs were investigated. Using molecular techniques and gene sequencing, the isolates were tested for antibiotic resistance, ESBL phenotypic detection, and bla OXA-48 and bla IMP gene identification. The SPSS software was used to do the statistical analysis. K. pneumoniae and E. coli, the two most common isolates, exhibit significant rates of resistance to commonly used antibiotics. Genesbla OXA-48 was present in 92.3% of E. coli isolates and 100% of K. pneumoniae isolates, and bla IMP was present in 43.1% of E. coli isolates and 25.7% of K. pneumoniae isolates. The amplified blaIMP-1 sequences of E. coli and K. pneumoniae did not show any nucleic acid variation in the samples under analysis. While the results of the alignment of the amplified bla OXA samples with K.pneumoniaeand E. coli revealed the existence of two nucleic acid variations referring to reference nucleic acid sequences of K. pneumoniae and E. coli, respectively. The study shows that K. pneumoniae and E. coli both have significant levels of the bla OXA-48 and bla IMP genes. To prevent the spread of bacteria that cause antibiotic-resistant UTIs in children’s populations, our results emphasise the need for increased surveillance and monitoring of antibiotic regimens.
Keywords:
Antibiotic resistance, bla IMP, bla OXA 48, E. coli, K. pneumonia, MDR, XDRReferences
Agbor, V. O., Ma’Ori, L., & Opajobi, S. O. (2011). Bacterial resistance to cephalosporins in clinical isolates in Jos University Teaching Hospital (JUTH). New York Science, 22(4), 9-13.
Bagnola, E. (2018). Urinary tract infections in a long-term care facility: a prevalence study (Bachelor's thesis, Kent State University).
Ballén, V., Gabasa, Y., Ratia, C., Ortega, R., Tejero, M., & Soto, S. (2021). Antibiotic resistance and virulence profiles of Klebsiella pneumoniae strains isolated from different clinical sources. Frontiers in Cellular and Infection Microbiology, 11, 738223. https://doi.org/10.3389/fcimb.2021.738223
Banerjee, S., Sengupta, M., & Sarker, T. K. (2017). Fosfomycin susceptibility among multidrug-resistant, extended-spectrum beta-lactamase-producing, carbapenem-resistant uropathogens. Indian Journal of Urology, 33(2), 149-154. https://doi.org/10.4103/iju.IJU_285_16
Chang, D., Sharma, L., Dela Cruz, C. S., & Zhang, D. (2021). Clinical epidemiology, risk factors, and control strategies of Klebsiella pneumoniae infection. Frontiers in microbiology, 12, 750662. https://doi.org/10.3389/fmicb.2021.750662
Chen, Y. T., Lin, J. C., Fung, C. P., Lu, P. L., Chuang, Y. C., Wu, T. L., & Siu, L. K. (2014). KPC-2-encoding plasmids from Escherichia coli and Klebsiella pneumoniae in Taiwan. Journal of Antimicrobial Chemotherapy, 69(3), 628-631. https://doi.org/10.1093/jac/dkt409
Gurung, S., Kafle, S., Dhungel, B., Adhikari, N., Thapa Shrestha, U., Adhikari, B., ... & Ghimire, P. (2020). Detection of OXA-48 gene in carbapenem-resistant Escherichia coli and Klebsiella pneumoniae from urine samples. Infection and drug resistance, 2311-2321. https://doi.org/10.2147/IDR.S259967
Jalil, M. B., & Al Atbee, M. Y. N. (2022). The prevalence of multiple drug resistance Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infections. Journal of clinical laboratory analysis, 36(9), e24619. https://doi.org/10.1002/jcla.24619
Jones, K. (2023). Considerations for extended spectrum beta-lactamase (esbl)-producers in nursing homes. MJH Life Sciences.
Karki, R. (2023). Multidrug resistance and extended spectrum β-lactamase producing Escherichia coli and klebsiella pneumoniae isolates from urine samples of patients attending a Hospital of Sunsari, Nepal (Doctoral dissertation, Department of Microbiology Central Campus of Technology, Dharan, Nepal TU Registration Number: 5-2-0003-0451-2013 2023 Tribhuvan University).
Li, W., Guo, H., Gao, Y., Yang, X., Li, R., Li, S., ... & Li, X. (2022). Comparative genomic analysis of plasmids harboring bla OXA-48-like genes in Klebsiella pneumoniae. Frontiers in Cellular and Infection Microbiology, 12, 1082813. https://doi.org/10.3389/fcimb.2022.1082813
Logan, L. K., & Weinstein, R. A. (2017). The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace. The Journal of infectious diseases, 215(suppl_1), S28-S36. https://doi.org/10.1093/infdis/jiw282
Mancuso, G., Midiri, A., Gerace, E., Marra, M., Zummo, S., & Biondo, C. (2023). Urinary tract infections: the current scenario and future prospects. Pathogens, 12(4), 623. https://doi.org/10.3390/pathogens12040623
Minardi, D., d’Anzeo, G., Cantoro, D., Conti, A., & Muzzonigro, G. (2011). Urinary tract infections in women: etiology and treatment options. International journal of general medicine, 333-343. https://doi.org/10.2147/IJGM.S11767
Mohammed, A. B., & Anwar, K. A. (2022). Phenotypic and genotypic detection of extended spectrum beta lactamase enzyme in Klebsiella pneumoniae. PloS one, 17(9), e0267221. https://doi.org/10.1371/journal.pone.0267221
Najjuka, C. F., Kateete, D. P., Kajumbula, H. M., Joloba, M. L., & Essack, S. Y. (2016). Antimicrobial susceptibility profiles of Escherichia coli and Klebsiella pneumoniae isolated from outpatients in urban and rural districts of Uganda. BMC research notes, 9, 1-14. https://doi.org/10.1186/s13104-016-2049-8
Pishtiwan, A. H., & Khadija, K. M. (2019). Prevalence of blaTEM, blaSHV, and blaCTX-M genes among ESBL-producing Klebsiella pneumoniae and Escherichia coli isolated from thalassemia patients in Erbil, Iraq. Mediterranean journal of hematology and infectious diseases, 11(1), e2019041. https://doi.org/10.4084/MJHID.2019.041
Poirel, L., Potron, A., & Nordmann, P. (2012). OXA-48-like carbapenemases: the phantom menace. Journal of Antimicrobial Chemotherapy, 67(7), 1597-1606. https://doi.org/10.1093/jac/dks121
Rahman, S., Ali, T., Ali, I., Khan, N. A., Han, B., & Gao, J. (2018). The growing genetic and functional diversity of extended spectrum beta‐lactamases. BioMed research international, 2018(1), 9519718. https://doi.org/10.1155/2018/9519718
Rizwan, M., Akhtar, M., Najmi, A. K., & Singh, K. (2018). Escherichia coli and Klebsiella pneumoniae sensitivity/resistance pattern towards antimicrobial agents in primary and simple urinary tract infection patients visiting university hospital of Jamia Hamdard New Delhi. Drug research, 68(07), 415-420. https://doi.org/10.1055/a-0576-0079
Singh, S., Pathak, A., Fatima, N., Sahu, C., & Prasad, K. N. (2023). Characterisation of OXA-48-like carbapenemases in Escherichia coli and Klebsiella pneumoniae from North India. 3 Biotech, 13(5), 134. https://doi.org/10.1007/s13205-023-03537-8
Wang, F., Wang, L., Chen, H., Li, N., Wang, Y., Li, Y., & Liang, W. (2021). Rapid detection of bla KPC, bla NDM, bla OXA-48-like and bla IMP carbapenemases in enterobacterales using recombinase polymerase amplification combined with lateral flow strip. Frontiers in Cellular and Infection Microbiology, 11, 772966. https://doi.org/10.3389/fcimb.2021.772966
Zhang, F., Li, Q., Bai, J., Ding, M., Yan, X., Wang, G., ... & Zhou, Y. (2021). Heteroresistance to amikacin in carbapenem-resistant Klebsiella pneumoniae strains. Frontiers in Microbiology, 12, 682239. https://doi.org/10.3389/fmicb.2021.682239
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Biomedicine and Chemical Sciences

This work is licensed under a Creative Commons Attribution 4.0 International License.














